Form D · Biotechnology
aTYR PHARMA INC
San Diego, CA · CIK 0001339970
Offering snapshot reported Sep 15, 2017 · SEC filing
- Reported sold
- $45.8M Offering amount: $45.8M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 31, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 15, 2017 | Initial | $45,849,982 | No comparison | 11 | SEC filing |
| Apr 2, 2015 | Initial | $76,278,755 | No comparison | 42 | SEC filing |
| Dec 13, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 23, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.83M
- Finders' fees
- $0
- Form D file number
- 021-294795
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Piper Jaffray & Co. | 665 |
Source: Form D, filed Sep 15, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Srini Akkaraju | Director |
| James C. Blair | Director |
| John T. Blake | Executive |
| Frederic Chereau | Executive |
| John K. Clarke | Director |
| Timothy P. Coughlin | Director |
| Kathryn Falberg | Director |
| Mark Goldberg | Director |
| Jeffrey S. Hatfield | Director |
| Nancy D. Krueger | Executive |
| John D. Mendlein | Director, Executive |
| Amir Nashat | Director |
| Amir H. Nashat, Sc.D. | Director |
| Ed Penhoet | Director |
| Sanuj K. Ravindran | Executive |
| Paul Schimmel | Director |
| Sanjay S. Shukla | Executive |
| Akkaraju Srinivas | Director |
| David Weiner | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3545 John Hopkins Court, Ste #250
San Diego, CA, 92121
San Diego, CA, 92121